These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31498088)

  • 1. Gavi sets US$7·4 billion replenishment target.
    Usher AD
    Lancet; 2019 Sep; 394(10201):817-818. PubMed ID: 31498088
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
    Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
    Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAVI gears up for record replenishment.
    Usher AD
    Lancet; 2014 Jul; 384(9939):219-20. PubMed ID: 25050437
    [No Abstract]   [Full Text] [Related]  

  • 6. The GAVI Financing Task Force: one model of partner collaboration.
    Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
    Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
    Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
    Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Brooks A; Habimana D; Huckerby G
    Vaccine; 2017 Apr; 35(17):2110-2114. PubMed ID: 28364917
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First countries to be recipients of GAVI funds.
    Maurice J
    Bull World Health Organ; 2000; 78(12):1477-8. PubMed ID: 11196504
    [No Abstract]   [Full Text] [Related]  

  • 11. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
    Balaji KA
    Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizing the world.
    Gates B; Gates M
    Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
    [No Abstract]   [Full Text] [Related]  

  • 17. UNICEF asks donors to give poorer nations longer-term commitment.
    Ahmad K
    Lancet; 2002 Jun; 359(9322):2009. PubMed ID: 12076567
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.
    Clemens J; Holmgren J; Kaufmann SH; Mantovani A
    Nat Immunol; 2010 Dec; 11(12):1069-72. PubMed ID: 21079627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAVI funding meeting exceeds expectations.
    Usher AD
    Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
    Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
    Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.